Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $73000.0.

  • IceCure Medical's Depreciation & Amortization (CF) fell 1204.82% to $73000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $306000.0, marking a year-over-year decrease of 810.81%. This contributed to the annual value of $332000.0 for FY2024, which is 278.64% up from last year.
  • According to the latest figures from Q3 2025, IceCure Medical's Depreciation & Amortization (CF) is $73000.0, which was down 1204.82% from $62000.0 recorded in Q2 2025.
  • Over the past 5 years, IceCure Medical's Depreciation & Amortization (CF) peaked at $89000.0 during Q1 2025, and registered a low of $23000.0 during Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $74000.0 (2022), whereas its average is $66000.0.
  • Per our database at Business Quant, IceCure Medical's Depreciation & Amortization (CF) surged by 12608.7% in 2022 and then crashed by 2439.02% in 2025.
  • IceCure Medical's Depreciation & Amortization (CF) (Quarter) stood at $41000.0 in 2021, then skyrocketed by 80.49% to $74000.0 in 2022, then grew by 12.16% to $83000.0 in 2023, then fell by 1.2% to $82000.0 in 2024, then fell by 10.98% to $73000.0 in 2025.
  • Its last three reported values are $73000.0 in Q3 2025, $62000.0 for Q2 2025, and $89000.0 during Q1 2025.